Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.
Sofi MH, Wu Y, Schutt SD, Dai M, Daenthanasanmak A, Heinrichs Voss J, Nguyen H, Bastian D, Iamsawat S, Selvam SP, Liu C, Maulik N, Ogretmen B, Jin J, Mehrotra S, Yu XZ.
Sofi MH, et al. Among authors: schutt sd.
J Clin Invest. 2019 May 2;129(7):2760-2774. doi: 10.1172/JCI122899.
J Clin Invest. 2019.
PMID: 31045571
Free PMC article.